These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 19307989)
1. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989 [TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337 [TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
4. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation. Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K Front Immunol; 2018; 9():125. PubMed ID: 29456534 [TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Green EA; Gorelik L; McGregor CM; Tran EH; Flavell RA Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10878-83. PubMed ID: 12949259 [TBL] [Abstract][Full Text] [Related]
6. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299 [TBL] [Abstract][Full Text] [Related]
7. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311 [TBL] [Abstract][Full Text] [Related]
9. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. Oida T; Weiner HL PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Lu L; Ma J; Wang X; Wang J; Zhang F; Yu J; He G; Xu B; Brand DD; Horwitz DA; Shi W; Zheng SG Eur J Immunol; 2010 Jan; 40(1):142-52. PubMed ID: 19943263 [TBL] [Abstract][Full Text] [Related]
11. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells. Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093 [TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses. Konkel JE; Zhang D; Zanvit P; Chia C; Zangarle-Murray T; Jin W; Wang S; Chen W Immunity; 2017 Apr; 46(4):660-674. PubMed ID: 28423340 [TBL] [Abstract][Full Text] [Related]
13. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells. Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147 [TBL] [Abstract][Full Text] [Related]
14. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function. Shevach EM; Davidson TS; Huter EN; Dipaolo RA; Andersson J J Clin Immunol; 2008 Nov; 28(6):640-6. PubMed ID: 18810612 [TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells induced the enrichment of CD4 Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398 [TBL] [Abstract][Full Text] [Related]
16. Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity. Petrausch U; Jensen SM; Twitty C; Poehlein CH; Haley DP; Walker EB; Fox BA J Immunol; 2009 Sep; 183(6):3682-9. PubMed ID: 19692636 [TBL] [Abstract][Full Text] [Related]
17. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. Gnerlich JL; Mitchem JB; Weir JS; Sankpal NV; Kashiwagi H; Belt BA; Porembka MR; Herndon JM; Eberlein TJ; Goedegebuure P; Linehan DC J Immunol; 2010 Oct; 185(7):4063-71. PubMed ID: 20805420 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422 [TBL] [Abstract][Full Text] [Related]
19. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+)Foxp3(+) Treg cells. Liu G; Duan K; Ma H; Niu Z; Peng J; Zhao Y Immunol Cell Biol; 2011 Nov; 89(8):827-35. PubMed ID: 21844881 [TBL] [Abstract][Full Text] [Related]
20. Expansion of Host Regulatory T Cells by Secreted Products of the Tapeworm Nono JK; Lutz MB; Brehm K Front Immunol; 2020; 11():798. PubMed ID: 32457746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]